fluoxetine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, WJ; Jarvis, MF; Wagner, GC | 2 |
| Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
| Andrews, AM; Murphy, DL | 2 |
| Ackland, MJ; Alex, AA; de Groot, MJ; Horne, VA; Jones, BC | 1 |
| He, XJ; Nakayama, H; Shibui, Y; Uchida, K | 1 |
| Bok, E; Chung, ES; Chung, YC; Jin, BK; Jin, M; Kim, SR; Kim, YS; Ko, HW; Park, ES; Park, JY; Park, KW; Won, SY; Yoon, SH | 1 |
| Chung, YC; Jin, BK; Kim, KI | 1 |
9 other study(ies) available for fluoxetine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Astrocytes as a primary locus for the conversion MPTP into MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Astrocytes; Biotransformation; Corpus Striatum; Dopamine; Fluoxetine; Male; Mice; Monoamine Oxidase; Neurotoxins; Pyridines; Pyridinium Compounds; Reference Values; Serotonin | 1989 |
Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Corpus Striatum; Dopamine; Fluoxetine; Male; Neurotoxins; Propylamines; Pyridines; Rats; Rats, Inbred Strains; Serotonin | 1988 |
Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Clomipramine; Corpus Striatum; Desipramine; Dopamine; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Nomifensine; Norepinephrine; Pyridines; Serotonin Antagonists | 1985 |
Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Body Temperature; Brain Chemistry; Carrier Proteins; Chromatography, High Pressure Liquid; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters | 1993 |
2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neuro
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cerebral Cortex; Clorgyline; Desipramine; Fluoxetine; Hippocampus; Male; Mice; Monoamine Oxidase Inhibitors; MPTP Poisoning; Neurotransmitter Uptake Inhibitors; Norepinephrine; Paroxetine; Selegiline; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission; Time Factors | 1993 |
A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Betaxolol; Cytochrome P-450 CYP2D6; Dealkylation; Fluoxetine; Loratadine; Models, Molecular; Pharmaceutical Preparations; Procainamide; Ritonavir; Substrate Specificity; Sumatriptan | 1999 |
MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Uptake Inhibitors; Adult Stem Cells; Animals; Apoptosis; Cerebral Ventricles; Desipramine; Dopamine Uptake Inhibitors; Drug Interactions; Fluoxetine; Gene Expression Regulation; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurotoxins; Neurotransmitter Transport Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Tetrabenazine | 2009 |
Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell Count; Coculture Techniques; Corpus Striatum; Cytokines; Dopamine; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Microglia; MPTP Poisoning; NADPH Oxidases; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress; Recovery of Function; Rotarod Performance Test; Substantia Nigra | 2011 |
Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Fluoxetine; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2018 |